Conditional approval extended through December 2026 for the treatment of CID in dogs CID confirmatory effectiveness trial ...

Physicians stand to earn big money when signing up patients for drug trials. And lately, some of those trials have been ...

The effectiveness of chemotherapy for brain cancer, done with a technique that opens the blood-brain barrier, can be ...

Cancer is one of the leading causes of death in the U.S., second only to heart disease. But a new cancer treatment method ...

Losing out on hair during cancer treatments is a common side effect, which creates a sense of agony and tension in some, ...

Forskolin, a plant-derived compound, shows surprising potential against one of the most aggressive forms of leukemia.

Cancer is one of the leading causes of death in the U.S., second only to heart disease. But a new cancer treatment method ...

Over time, clonal expansion leads to an increase in the frequency of infected cells in a patient. The proviruses in daughter ...

The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's Enhertu in combination with Roche ...

At the recent American Society of Hematology (ASH) meeting, researchers presented early data from a phase II study evaluating ...

Pfizer’s Tukysa added to maintenance therapy significantly delayed disease progression in patients with HER2-positive ...